BeOne Medicines
Naisargee Shah (Parikh), Ph.D. is a seasoned professional in clinical science and development, currently serving as Director at BeiGene since January 2024. Previously, Naisargee held senior leadership positions at Rain Oncology and Puma Biotechnology, where responsibilities included advising on clinical development strategy, presenting clinical data at governance meetings, and managing regulatory submissions. Naisargee's extensive experience encompasses roles at Cordis, Stanford University School of Medicine, and a startup, alongside research positions at the Department of Science and Technology in India and Bristol Myers Squibb. Academic credentials include a Bachelor's degree in Pharmacy, a Master of Science in Medicinal and Pharmaceutical Chemistry, and a Ph.D. in the same field from esteemed institutions.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.